Form D · Other Health Care
NexGelRx, Inc.
Langhorne, PA · CIK 0002104736
Offering snapshot reported Jan 14, 2026 · SEC filing
- Reported sold
- $1.25M Offering amount: $1.25M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2026 | Initial | $1,250,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $97K
- Finders' fees
- $0
- Form D file number
- 021-570003
In addition to the cash commission, the broker dealer received 4% - 8% warrants on investors.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Alere Financial Partners, A Division of Cova Capital Partners, LLC | 000109761 |
Source: Form D, filed Jan 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kip J. Crecca | Director |
| Steven M. Glassman | Director |
| Robert L. Gottlieb | Director |
| Richard S. Myers | Director, Executive |
| Jerome B. Zeldis | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2150 Cabot Boulevard West Suite B
Langhorne, PA, 19047
Langhorne, PA, 19047